Ascletis
North America, North Carolina, United States, Chapel Hill
Description
Ascletis is a specialty therapeutics company developing therapeutics for the treatment of cancer and infectious diseases.
Investor Profile
Ascletis has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series E, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biopharma, Biotechnology, Therapeutics.
Stage Focus
- Series E (67%)
- Series Unknown (33%)
Country Focus
- United States (100%)
Industry Focus
- Biopharma
- Biotechnology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Ascletis frequently co-invest with?
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
What are some of recent deals done by Ascletis?
Find More Investors Like Ascletis
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
